Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35902523)
Watch
English
Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.
scientific article published in September 2004
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15450242
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15450242%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Oncolytic viruses for the treatment of cancer: current strategies and clinical trials
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15450242
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15450242%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
main subject
oncolytic virus
1 reference
based on heuristic
inferred from title
author
Christian H Brandts
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15450242
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15450242%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
author name string
Stefan J Ries
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15450242
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15450242%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
language of work or name
English
1 reference
based on heuristic
inferred from title
publication date
1 September 2004
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15450242
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15450242%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
published in
Drug Discovery Today
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15450242
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15450242%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
volume
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15450242
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15450242%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
issue
17
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15450242
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15450242%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
page(s)
759-768
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15450242
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15450242%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
cites work
Replication-selective viruses for cancer therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic viruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Principles of tumor immunosurveillance and implications for immunotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RNA viruses as virotherapy agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reovirus as a novel oncolytic agent
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vectors based on autonomous parvoviruses: novel tools to treat cancer?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antineoplasic activity of parvoviruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic herpes simplex virus vectors for cancer virotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravascular adenoviral agents in cancer patients: lessons from clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intergeneric poliovirus recombinants for the treatment of malignant glioma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral transactivating proteins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
E1A signaling to p53 involves the p19(ARF) tumor suppressor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ONYX-015 selectivity and the p14ARF pathway
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modifications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Telomerase-dependent oncolytic adenovirus for cancer treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene therapy using tissue-specific replication competent HSV.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ligand-directed targeting of genes to the site of disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Engineered herpes simplex virus 1 is dependent on IL13Ralpha 2 receptor for cell entry and independent of glycoprotein D receptor interaction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systemic tumor targeting and killing by Sindbis viral vectors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intralesional injection of herpes simplex virus 1716 in metastatic melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MTH-68/H oncolytic viral treatment in human high-grade gliomas.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene therapy for killing p53-negative cancer cells: use of replicating versus nonreplicating agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The complement response against an oncolytic virus is species-specific in its activation pathways
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903221-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1359-6446(04)03221-0
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15450242
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15450242%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
PubMed publication ID
15450242
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15450242
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15450242%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
